Apoco blood analysis system
Taiwan·Risk Class 2·Siemens Healthcare Diagnostics Inc.;; EPOCAL INC.·Registered Aug 28, 2024 – Aug 28, 2029Active- Analysis ID
- 296cc79a18b9b3467ac5ebafa65d71d9
- Customs Code
- DHA05603710000
- Manufacturer Country
- Canada;;United States
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
- Intended Use
- This product is an in vitro diagnostic device for use with an EPOC-specific cassette and is intended for use by trained professionals in the laboratory or point-of-care as a semi-automated in vitro diagnostic device for the quantitative testing of heparinized or non-anticoagulated arterial, venous, or microvascular whole blood human samples.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1450 Lactate Test System;; A.1665 Sodium Test System;; A.1160 Bicarbonate/CO2 Test System
- Import Information
- QMS/QSD;; 輸入
- Registration Date
- Aug 28, 2024
- Expiry Date
- Aug 28, 2029
Top companies providing products similar to "Apoco blood analysis system"
Recently registered similar products
Access comprehensive regulatory information for Apoco blood analysis system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 296cc79a18b9b3467ac5ebafa65d71d9 and manufactured by Siemens Healthcare Diagnostics Inc.;; EPOCAL INC.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Siemens Healthcare Diagnostics Inc.;; EPOCAL INC., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.